Susanne Somerville, CEO of life sciences information sharing consulting firm Chronicled, thinks blockchain technology could be the solution to 340B duplicate discounts.

Tech Firm Convening Working Group to Address 340B Duplicate Discounts

A Bay Area health care tech firm is convening a work group to try to solve the problem of duplicate 340B discounts and Medicaid rebates on the same drugs.

San Francisco-based Chronicled said in a statement issued on Tuesday its goal is to “bring together pharmaceutical manufacturers, 340B covered entities, and state/federal agencies, to establish the business requirements, conceptual design, and proof of concept for an industrywide solution to Medicaid duplicate discounts.”

A Bay Area health care tech firm is convening a work group to try to solve the problem of duplicate 340B discounts and Medicaid rebates on the same drugs.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report